Patents by Inventor Pulak Kumar Metia

Pulak Kumar Metia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE
    Publication number: 20230285301
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 14, 2023
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • Multi-particulate pharmaceutical composition of quetiapine
    Patent number: 11690805
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: July 4, 2023
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Amit Kumar, Ravindra Agarwal, Pulak Kumar Metia, Kalaiselvan Ramaraju, Sumit Madan, Romi Barat Singh
  • MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE
    Publication number: 20220105040
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: December 14, 2021
    Publication date: April 7, 2022
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB
    Publication number: 20170049774
    Abstract: The present invention relates to sustained release oral pharmaceutical compositions of tofacitinib comprising tofacitinib, a release controlling polymer, and pharmaceutically acceptable excipients, wherein the sustained release oral pharmaceutical compositions further comprise an outer modified release coating that includes a modified release polymer. The invention also relates to a process for the preparation of the compositions.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 23, 2017
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Sandeep Kumar VATS, Pulak Kumar METIA, Balamurali Krishna NOOKA
  • Pharmaceutical composition of doxycycline with reduced food effect
    Patent number: 9566287
    Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: February 14, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
  • Doxycycline composition
    Patent number: 9561242
    Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: February 7, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
  • Pharmaceutical composition of doxycycline with reduced food effect
    Patent number: 9463196
    Abstract: The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: October 11, 2016
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
  • PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT
    Publication number: 20160151396
    Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.
    Type: Application
    Filed: February 2, 2016
    Publication date: June 2, 2016
    Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI
  • DOXYCYCLINE COMPOSITION
    Publication number: 20160151397
    Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.
    Type: Application
    Filed: February 2, 2016
    Publication date: June 2, 2016
    Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI
  • PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT
    Publication number: 20160082021
    Abstract: The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI
  • Pharmaceutical composition of doxycycline
    Patent number: 9132092
    Abstract: The present invention relates to a pharmaceutical composition comprising (i) 50% to 99% of doxycycline as an immediate-release portion; (ii) 1% to 50% of doxycycline as a controlled-release portion; and (iii) one or more pharmaceutically acceptable excipients; wherein the pharmaceutical composition provides a total daily dosage of 40 mg when administered once daily. It also relates to process for preparation of the pharmaceutical composition and its use for treating rosacea.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: September 15, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni
  • Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof
    Publication number: 20110177164
    Abstract: A stabilized pharmaceutical composition of benzimidazole compounds preferably amorphous form of esomeprazole and a process for preparing the same. The pharmaceutical compositions formulated into solid dosage forms preferably multiple unit tablet dosage forms and capsules and a method for preparing the same.
    Type: Application
    Filed: October 6, 2009
    Publication date: July 21, 2011
    Inventors: Gopal Rajan, Pratik Kumar, Gour Mukherji, Pulak Kumar Metia